Koyfin Home > Directory > Health Care > Amgen Inc > EBIT

Amgen Inc EBIT Chart (AMGN)

Amgen Inc annual/quarterly EBIT from 2010 to 2020. Earnings before interest and taxes measures the profit a company generates from its operations, making it synonymous with operating profit. By ignoring tax and interest expenses, it focuses solely on a company's ability to generate earnings from operations, ignoring variables such as the tax burden and capital structure.
  • Amgen Inc EBIT for the quarter ending September 09, 2020 was $2,454m a 14.63% increase of 359m year over year
  • Amgen Inc EBIT for the last 12 months ending September 09, 2020 was $9,226m a -5.37% decrease of -495m year over year
  • Amgen Inc Annual EBIT for 2019 was $9,721m a -8.54% decrease of -830m from 2018
  • Amgen Inc Annual EBIT for 2018 was $10,551m a 2.00% increase of 211m from 2017
  • Amgen Inc Annual EBIT for 2017 was $10,340m a 4.91% increase of 508m from 2016
Other Income Statement Metrics:
  • Amgen Inc EBITDA for the quarter ending December 12, 2018 was $2,883m a -10.75% decrease of -310m year over year
  • Amgen Inc Net Income for the quarter ending December 12, 2018 was $1,928m a -19.87% decrease of -383m year over year
  • Amgen Inc Total Revenue for the quarter ending December 12, 2018 was $6,230m a 10.85% increase of 676m year over year
View Chart On Koyfin

Quarterly AMGN EBIT Data

09/2020$2,454m
06/2020$2,323m
03/2020$2,355m
12/2019$2,095m
09/2019$2,476m
06/2019$2,678m
03/2019$2,472m
12/2018$2,340m
09/2018$2,653m
06/2018$2,832m

Annual AMGN EBIT Data

2019$9,721m
2018$10,551m
2017$10,340m
2016$9,832m
2015$8,629m
2014$6,765m
2013$6,105m
2012$5,969m
2011$5,219m
2010$5,592m